Neil Ashe, an officer of Acuity Inc. (DE), filed a Form 144 notice of proposed sale of 22,060 shares of common stock on October 28, 2026, through Merrill Lynch under a Rule 10b5-1 plan adopted on July 1, 2026.
Key Highlights
- Seller and role: Neil Ashe, identified as an officer of Acuity Inc. (DE)
- Shares proposed for sale: 22,060 shares of common stock, with an aggregate market value of $7,000,217.88, according to the filing
- Shares outstanding: 29,695,521 shares of common stock outstanding, as reported in the filing
- Approximate date of sale: October 28, 2026, on the NYSE
- 10b5-1 plan date: The plan was adopted on July 1, 2026
- Acquisition sources: Shares were acquired through vesting of restricted stock unit awards and performance share unit awards granted as part of the issuer's equity compensation plan, with vesting dates ranging from October 24, 2025 to October 24, 2026
- Prior sales: The filing reports nothing to report for securities sold during the past three months
Acuity Inc. Officer Neil Ashe Files Rule 144 Notice for Proposed Common Stock Sale
According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Neil Ashe, an officer of Acuity Inc. (DE), listed on NYSE, is proposing to sell 22,060 shares of Acuity Inc. common stock. The broker named in the filing is Merrill Lynch, located at 225 Liberty Street, Floor 37, New York, NY 10281. The aggregate market value of the shares proposed for sale is stated as $7,000,217.88, with 29,695,521 total shares outstanding at the time of the notice.
The filing identifies four separate tranches of shares underlying the proposed sale, all acquired through the issuer's equity compensation plan. Specifically, the filing lists 3,000 shares vesting from restricted stock unit awards on October 24, 2025; 3,010 shares vesting from restricted stock unit awards on October 24, 2026; 14,460 shares vesting from performance share unit awards on October 24, 2026; and 1,590 shares vesting from restricted stock unit awards on October 23, 2026. All tranches are described as having been granted as part of the issuer's equity compensation plan, with Acuity Inc. (DE) named as the person from whom the shares were acquired in each case.
The notice indicates that Ashe is relying on a Rule 10b5-1 written trading plan, with the date of plan adoption listed as July 1, 2026. The filing reports no securities sold by Ashe in the three months preceding this notice. By signing the form, Ashe represents, as of the plan adoption date, that he did not know any material adverse information regarding the issuer's current and prospective operations that had not been publicly disclosed, as stated in the filing's standard attestation language.
What Was Disclosed
Acuity Inc. (DE) officer Neil Ashe filed a Form 144 notice dated October 28, 2026, disclosing a proposed sale of 22,060 shares of common stock valued at $7,000,217.88, acquired through equity compensation plan vesting events, under a 10b5-1 plan adopted July 1, 2026.



Please wait processing your request...